What's Happening?
Oneskin, a California-based skincare brand focused on longevity, has received a $20 million investment from Prelude Growth Partners. This investment replaces a former investor without diluting other shareholders' equity. Founded in 2021 by Brazilian scientists, Oneskin utilizes a proprietary peptide, OS-01, claimed to have anti-aging properties. The brand primarily sells through its e-commerce site and Amazon, with a significant portion of sales coming from subscriptions. Prelude Growth Partners has a history of investing in beauty brands, including Sol de Janeiro and Summer Fridays.
AD
Why It's Important?
The investment from Prelude Growth Partners provides Oneskin with financial stability and resources to expand its operations and enhance its product offerings. This funding will support clinical trials, a brand refresh, and new hires, positioning Oneskin for growth in the competitive skincare market. The backing from a reputable growth equity firm underscores the potential of Oneskin's innovative approach to skincare, which could influence industry trends towards longevity-focused products.
What's Next?
Oneskin plans to use the investment to explore retail entry by 2027 and continue product development and marketing efforts. The company is also recruiting key personnel, including a head of brand and chief marketing officer, to drive its growth strategy. As Oneskin expands its operations, it may attract further investments and partnerships, potentially leading to increased market presence and consumer engagement.
